Lv31
354 积分 2025-04-08 加入
Addressing unmet needs in chronic myeloid leukemia in chronic phase treated with two or more tyrosine kinase inhibitors: insights from literature and Indian clinical practice
1个月前
已完结
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase
1个月前
已完结
Second attempt to discontinue TKI after molecular relapse in patients with chronic myeloid leukemia: A real-life Italian multicenter study
1个月前
已完结
A multicenter phase 2 trial in children and young adults with newly diagnosed T-ALL: ALL-T11/ T-ALL-211-U from the Japan Children's Cancer Group and the Japan Adult Leukemia Study Group
4个月前
已关闭
Toward Equitable Risk Classification for All Patients with T-ALL
4个月前
已完结
Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium
4个月前
已关闭
Nilotinib versus imatinib with early switch from imatinib tonilotinib to obtain treatment-free remission in newly diagnosedchronic myeloid leukemia patients: the analysis of the frstco-primary endpoint
4个月前
已完结
Efficacy, safety and predictive biomarker of third‐generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia
4个月前
已完结
皖公网安备34019202002308
